Navigation Links
Study Suggests Way to 'Mop Up' Leukemia Cells
Date:1/8/2010

Vaccine beats back cancer left behind after treatment, researchers say,,,,

FRIDAY, Jan. 8 (HealthDay News) -- Preliminary research suggests that a vaccine could help reduce the risk of a relapse in some people who take the drug Gleevec to treat chronic myeloid leukemia.

"Should this vaccine approach prove to be successful, the ability to get patients off lifelong Gleevec therapy would be a significant advance," Dr. Hyam Levitsky, a professor of oncology, medicine and urology at the Johns Hopkins Kimmel Cancer Center in Baltimore, said in a news release from the center.

Imatinib mesylate (Gleevec) treats chronic myeloid leukemia, but can leave some cancerous cells behind. They can cause a relapse.

Researchers from the cancer center tested a vaccine on 19 people who had cancerous cells even though they'd taken Gleevec for a year. After about 72 months, the number of cancer cells had declined in 13 people. In seven, the cancer had vanished. Reported side effects of the treatment were relatively rare.

But it's not clear if the results were actually caused by the vaccine, the researchers said, because of the small number of participants and the lack of comparison with other treatments.

"We want to get rid of every last cancer cell in the body," Levitsky said, "and using cancer vaccines may be a good way to mop up residual disease."

The vaccine was made from cancer cells that were blasted with radiation to stop them from being cancerous, the researchers said.

The research, funded by the U.S. National Institutes of Health, was published in the Jan. 1 issue of Clinical Cancer Research.

More information

The U.S. National Cancer Institute has more on Gleevec.



-- Randy Dotinga



SOURCE: Johns Hopkins Kimmel Cancer Center, news release, Jan. 6, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Periodic Paralysis Study Reveals Gene Causing Disorder
2. UCLA study shows metformin is safe for patients with advanced heart failure and diabetes mellitus
3. Technology new gateway into treatment for problem alcohol users: Study
4. Few breast cancer surgeons follow quality of care standards, U-M study finds
5. Study shows serious emotional disturbances among children after Katrina
6. Study links restless leg syndrome with erectile dysfunction in older men
7. Study identifies those elderly most at risk for major depression
8. Despite Earlier Doubts, Feinstein Study Shows Fetal Transplants May Benefit Parkinson's Patients Over Age 60
9. New Study Shows That American Public is Willing to Accept Major Reforms in Medicare Program
10. Herbal Science Organization Clarifies New Ginkgo Study
11. CRN Responds to Ginkgo Biloba Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a ... fitness app plans to fix the two major problems leading the fitness industry today:, ... type program , They don’t eliminate all the reasons people quit their exercise ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... Calif. , June 23, 2016 ... CST on Thursday, July 7, 2016 , , , , ... ) , , , , EXPERT PANELISTS:  , , ... Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar ... The global pharmaceutical industry is witnessing an exceptional ...
(Date:6/23/2016)... -- Revolutionary technology includes multi-speaker listening to ... leaders in advanced audiology and hearing aid technology, has ... the world,s first internet connected hearing aid that opens ...      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ) , ... firsts,: , TwinLink™ - the first dual ...
Breaking Medicine Technology: